A unique comparative study of five vaccines, conducted in Hungary, in 3,7 million people, shows that Sputnik V is the best vaccine to protect against covid-19 mortality with an efficacy of 98% and an efficacy of 85,7 % against infection, according to agencies.
According to the results of the study, published on the Russian vaccine social network Twitter, within the framework of the independent investigation, data at the national level were analyzed on the efficacy of five of the most popular vaccines against coronavirus: Sputnik V , Moderna, Pfizer-BioNTech, Sinopharm and AstraZeneca.
The study found that the Russian vaccine has the highest efficacy (98%) in preventing COVID-19-related mortality. In addition, Sputnik V is 85,7% effective against coronavirus infection, giving it a technical tie with Moderna's vaccine for first place.
"The study has also shown that Sputnik V is 100% effective against COVID-related deaths in people aged 16 to 44 years," details the official website of the Russian drug.
The research, which analyzed the real data regarding the vaccination of 3,7 million citizens in Hungary, has been published in the scientific journal Clinical Microbiology and Infection.
The analyzed data was provided by the Hungarian National Center for Public Health, the first member state of the European Union to authorize the use of Sputnik V.
The information analyzed in the framework of the study refers to the vaccination against COVID-19 carried out in Hungary between January 22, 2021 and June 10, 2021.
Hungary was the first EU country to authorize Sputnik V. The article analyzes data from the National Public Health Center (NPHC).
Between January 22, 2021 and June 10, 2021, Hungarian residents received two doses of the Sputnik V, Moderna, Pfizer-BioNTech, Sinopharm, or AstraZeneca vaccines as part of the national vaccination program.
The Russian vaccine proved to be the best in protection against COVID-related mortality and leads alongside Moderna's vaccine in the rate of efficacy against infection, based on analysis of data from 820.000 people vaccinated with Sputnik V.